Work

Maternal Serum CA-125 in Placenta Previa with and Without Placenta Accreta Spectrum: No Association with Invasion Depth but a Possible Marker of Extrauterine Extension

Year: 2026
Type: article
Study design: Observational Study
Abstract: Background/Objectives: Predicting the extent of placental invasion before surgery remains challenging. We evaluated whether maternal serum CA-125 distinguishes placenta accreta spectrum (PAS) from placenta previa (PP) without PAS and whether it is associated with invasion severity. Methods: This cross-sectional study included 83 singleton third-trimester pregnancies: 22 with PP and histologically confirmed PAS, 21 with PP without PAS, and 40 controls without previous uterine surgery who delivered vaginally. Results: The groups differed in gestational age, parity, and previous cesarean deliveries. Median CA-125 was similar in the PAS, PP, and control groups (17.9, 17.3, and 18.9 U/mL; p = 0.700), including after adjustment for gestational age, and did not discriminate PAS from PP area under the curve [AUC] 0.505) or correlate with invasion depth. Women with extrauterine extension (n = 9) had higher CA-125 (24.6 vs. 16.0 U/mL; p = 0.015; AUC 0.768), an association that persisted after adjustment for gestational age and body mass index (odds ratio [OR] per 10 U/mL 1.95, 95% confidence interval [CI] 1.08–3.54). A cut-off of >17.7 U/mL yielded 88.9% sensitivity and 95.5% negative predictive value. Conclusions: CA-125 does not identify PAS or invasion depth. Its association with extrauterine extension in women with PP is hypothesis-generating and requires prospective validation.
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,137
OpenAlex ID: W7236726331
FWCI:
Cites: 30
Cited by:
Related to: 10